Dizziness Chronic Clinical Trial
Official title:
Safety, Effectiveness, and Cost-effectiveness of an Herbal Medicine, Gongjin-dan, in Subjects With Chronic Dizziness: a Prospective, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Clinical Trial
This is a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group, clinical trial to explore the effectiveness of an herbal medication, Gongjin-dan (GJD) for chronic dizziness (Ménière disease, psychogenic dizziness, or dizziness of unknown cause), identified as liver-deficiency pattern/syndrome, and assessed with Dizziness Handicap Inventory (DHI) ≥ 24 at baseline. Participants will be randomized and allocated to either GJD or placebo group with 1:1 ratio and orally administered GJD or placebo pills once a day for 8 weeks. For collecting data for cost-effectiveness analysis, the participants will be followed up to 12 months from randomization.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02048670 -
Pilot Project on External Vestibular Prosthesis in Chronic Subjective Dizziness
|
N/A | |
Recruiting |
NCT03034655 -
Reducing Rate of Falls in Older People by Means of Vestibular Rehabilitation (ReFOVeRe Study)
|
N/A | |
Completed |
NCT03317353 -
Reducing Rate of Falls in Older People by Means of Vestibular Rehabilitation: Preliminary Study
|
N/A | |
Completed |
NCT04268745 -
Virtual Environments for Vestibular Rehabilitation
|
N/A |